Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch PSE, a new accurate blood test for ...

Kearney Urology Center has reported a 50% reduction in biopsies since adopting EpiSwitch® PSE, a new accurate blood test for prostate cancer. The reduction is down to the marked improvement offered by ...

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...

Primarily used to screen for prostate cancer, PSA tests measure the level of prostate-specific antigen in the blood. “The ...

A top lawyer whose prostate cancer was discovered by chance in a routine health test is urging all men over 50 to get ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The primary methodologic issue with the PLCO trial is the high rate of PSA screening in the usual care group. Approximately 52% of men in the usual care group received a PSA test during the study.

This high level of contamination in the control ... approximately 44% of men had undergone one or more PSA test before randomization. These men had a prostate-cancer-specific mortality rate ...

There is a general consensus among clinicians that a serum prostate-specific antigen (PSA) level ≥4.0 ng/ml ... Phase III trial was designed to test the efficacy of daily finasteride treatment ...

A novel polygenic risk score (PRS) may be useful for identifying men on active surveillance (AS) for prostate cancer who are ...

A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...